is Senior Vice President at Genentech and Head of Global Technical Development at Roche. She is responsible for developing process and analytical technologies, scaling-up, manufacturing, control and delivering GMP clinical supplies for all products in the pipeline. Prior to joining Genentech in September 2005, Ann worked for 16 years at Merck & Co., Inc., where she held several leadership positions in vaccine development in the Merck Research Laboratories. She was project leader for a number of vaccines including PedvaxHIB, COMVAX, 2nd generation PNEUMOVAX23, and GARDASIL. She also served as Vice President, Chemical Technology and Engineering in the manufacturing division. Ann holds a Bachelor of Science in Chemical Engineering from Cornell University, and a PhD from Yale University. She is a member of the National Academy of Engineering, American Institute of Chemical Engineers, American Chemical Society, Society of Women Engineers, Sigma Xi, a Fellow of the American Institute of Medical and Biological Engineering, and serves on various academic and scientific advisory boards. She has been Associate Editor of Biotechnology and Applied Biochemistry, organizer of numerous conferences and an invited lecturer at various meetings and universities. Ann is actively involved in company-wide recruiting efforts and mentoring boys and girls in science.
is currently an Associate Director in Strategic Pricing and Contracting. In this role, she oversees development of pricing and contract strategies for the GMET therapeutic areas and customer segments that optimize the value of Genentech's portfolio, which includes providing leadership and management for cross-functional strategy development teams, scenario analysis/modelling for overall financial and legal viability, as well as ongoing pricing and contract performance assessment/analysis. Lis joined Genentech in 2001, and has held positions of increasing responsibility across the Research and Early Development, Medical Affairs, and Portfolio Strategy groups. She is co-chair and South San Francisco Founder of Genentech Women Professionals, a collaborative and supportive forum aimed at educating, supporting, and mentoring on issues unique to women in biotech. She is also a member of Out and Equal, Genentech’s group for the Lesbian, Gay, Bisexual and Transgender (LGBT) community and their allies. Prior to joining Genentech, she held multiple roles across companies in the pharma/biotech industry including Quintiles and ePocrates. Lis received her BA with honors in Human Biology from Stanford University, and her MBA from the University of California at Berkeley Haas School of Business. Lis lives in the San Francisco Bay Area with her partner and their 75-lb lapdog.
is Director of Process Development Operations and Engineering at Genentech. She leads an organization responsible for bioprocess technology development, automation engineering, pilot plant operations, and strategic planning. Tina has held positions of increasing responsibility in Engineering, Manufacturing, and Process Development during her 15 years at Genentech. She spent 11 years providing direct technical support to Bioprocess Manufacturing, as both an Automation Engineer and Manufacturing Scientist. She has worked with every commercial product at Genentech, and many clinical products. She also led the purification technology transfer for a contract manufacturing project. Tina is recognized in the pharmaceutical industry for her leadership in bioprocess analysis and control. Tina is also known for her commitment to mentorship and talent development, including her role as founding officer in Genentech’s Women Professionals group and her mentorship of emerging leaders through the NextGen program. Tina holds a B.S. in Chemical Engineering from Colorado State University. In her free time, Tina enjoys sharing her passion for gardening with her 3-year-old daughter, Kendra. Kendra has her own set of gardening tools and she has successfully cultivated her own flowers and peas.
is an engineer in Genentech's Late Stage Cell Culture department, which is responsible for developing, characterizing, validating and transferring cell culture processes for the production of therapeutic proteins. Melissa joined Genentech in 2004 after receiving B.S. and M.S. degrees in Chemical Engineering from Stanford University and recently transitioned to a management role in late 2009. Last fall she hit her six-year mark and spent her first sabbatical traveling in Europe.
Kristin Lowland Lanzi is Manager of Genentech Informatics Systems Operations. Kristin has been at Genentech for a little over six years in both Project Delivery and Management positions. In her current role, Kristin manages a team of Wintel/Unix System Administrators in the 24x7x365 operational support of computing systems (validated and non-validated) for Genentech’s global IT infrastructure. Kristin holds a bachelor's degree in political science and business from California Polytechnic State University, SLO, as well as, certifications in Project Management from the Project Management Institute and Stanford University (PMP and SCPM). She has a great love for the outdoors and recently climbed Kilimanjaro as part of her sabbatical.